When will the FDA approve Compass Pathways' COMP360 Psilocybin?

COMP360 Psilocybin for Treatment-Resistant DepressionScience and Technologyindependent outcomes

Markets

5 active

24h volume

contracts, all markets

Open interest

9,381

contracts, all markets

Series

Compass Pathways Drug Approval

Markets in this event

Sorted by 24h volume.

Market	Yes bid	Yes ask	Last	Δ	Spread	Vol 24h	OI	Vol total	Closes	Status
Will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression before Jan 1, 2027?Before Jan 1, 2027KXFDAAPPROVALDATECMPS-360-27JAN01	33¢	38¢	30¢	–	5¢	0	2,170	4,586	in 3mo	active
Will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression before Mar 1, 2027?

U.S. Food and Drug Administration.https://www.fda.gov/news-events/fda-newsroom/press-announcements
FDAhttps://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2026
Compass Pathwayshttps://compasspathways.com/

Show JSON (markets omitted)

event11